Shindo, Y.; Ioka, T.; Tokumitsu, Y.; Matsui, H.; Nakajima, M.; Kimura, Y.; Watanabe, Y.; Tomochika, S.; Nakagami, Y.; Tsunedomi, R.;
et al. Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. Cancers 2024, 16, 2522.
https://doi.org/10.3390/cancers16142522
AMA Style
Shindo Y, Ioka T, Tokumitsu Y, Matsui H, Nakajima M, Kimura Y, Watanabe Y, Tomochika S, Nakagami Y, Tsunedomi R,
et al. Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. Cancers. 2024; 16(14):2522.
https://doi.org/10.3390/cancers16142522
Chicago/Turabian Style
Shindo, Yoshitaro, Tatsuya Ioka, Yukio Tokumitsu, Hiroto Matsui, Masao Nakajima, Yuta Kimura, Yusaku Watanabe, Shinobu Tomochika, Yuki Nakagami, Ryouichi Tsunedomi,
and et al. 2024. "Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer" Cancers 16, no. 14: 2522.
https://doi.org/10.3390/cancers16142522
APA Style
Shindo, Y., Ioka, T., Tokumitsu, Y., Matsui, H., Nakajima, M., Kimura, Y., Watanabe, Y., Tomochika, S., Nakagami, Y., Tsunedomi, R., Iida, M., Takahashi, H., & Nagano, H.
(2024). Safety and Feasibility of Neoadjuvant-Modified FOLFIRINOX in Elderly Patients with Pancreatic Cancer. Cancers, 16(14), 2522.
https://doi.org/10.3390/cancers16142522
